Chong Kun Dang Pharmaceutical (185750) — Financial Flexibility Index
Chong Kun Dang Pharmaceutical (185750) has a Financial Flexibility Index of 0.11x as of March 2026. Free cash flow of ₩86.65 Billion (operating CF ₩12.32 Billion minus capex ₩74.34 Billion) represents 0% of total liabilities (₩803.02 Billion). Check Chong Kun Dang Pharmaceutical (185750) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chong Kun Dang Pharmaceutical Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Chong Kun Dang Pharmaceutical across 10 annual periods. See Chong Kun Dang Pharmaceutical short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Chong Kun Dang Pharmaceutical (2016–2025)
Year-by-year free cash flow to debt coverage for Chong Kun Dang Pharmaceutical. For the full company profile including market capitalisation, see 185750 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | ₩246.49 Billion | ₩67.36 Billion | ₩793.94 Billion | ▲ +33.9% |
| 2024 | 0.23x | ₩130.39 Billion | ₩64.29 Billion | ₩562.39 Billion | ▼ -64.8% |
| 2023 | 0.66x | ₩386.97 Billion | ₩318.16 Billion | ₩586.79 Billion | ▲ +194.9% |
| 2022 | 0.22x | ₩112.63 Billion | ₩67.73 Billion | ₩503.59 Billion | ▲ +75.9% |
| 2021 | 0.13x | ₩61.15 Billion | ₩12.90 Billion | ₩480.89 Billion | ▼ -63.4% |
| 2020 | 0.35x | ₩136.96 Billion | ₩104.32 Billion | ₩394.74 Billion | ▲ +14.2% |
| 2019 | 0.30x | ₩99.13 Billion | ₩77.29 Billion | ₩326.40 Billion | ▲ +32.0% |
| 2018 | 0.23x | ₩64.54 Billion | ₩42.63 Billion | ₩280.60 Billion | ▼ -37.9% |
| 2017 | 0.37x | ₩101.46 Billion | ₩81.67 Billion | ₩273.91 Billion | ▲ +9.5% |
| 2016 | 0.34x | ₩97.23 Billion | ₩57.79 Billion | ₩287.45 Billion | — |